Gilead Sciences
GILD
$64.27
Share price
0.30%
Change (1 day)
-15.67%
Change (1 year)
Categories
Gilead Sciences (GILD) - Net assets
Net assets on the balance sheet as of March 2024 : $17.45 B
According to Gilead Sciences's latest financial reports the company has $17.45 B in net assets.
A company’s net assets is the sum of its assets minus the sum of its liabilities.
Gilead Sciences - Net assets on balance sheet (from 2001 to 2024)
Net assets by year
| Year | Net assets | Change |
|---|---|---|
| 2023-12-31 | $22.74 B | 7.26% |
| 2022-12-31 | $21.20 B | 0.69% |
| 2021-12-31 | $21.06 B | 15.6% |
| 2020-12-31 | $18.22 B | -19.55% |
| 2019-12-31 | $22.65 B | 5.18% |
| 2018-12-31 | $21.53 B | 5.04% |
| 2017-12-31 | $20.50 B | 5.88% |
| 2016-12-31 | $19.36 B | 1.31% |
| 2015-12-31 | $19.11 B | 20.82% |
| 2014-12-31 | $15.81 B | 34.69% |
| 2013-12-31 | $11.74 B | 23.07% |
| 2012-12-31 | $9.54 B | 38.97% |
| 2011-12-31 | $6.86 B | 12.18% |
| 2010-12-31 | $6.12 B | -5.89% |
| 2009-12-31 | $6.50 B | 45.67% |
| 2008-12-31 | $4.46 B | 24.03% |
| 2007-12-31 | $3.60 B | 92.65% |
| 2006-12-31 | $1.86 B | -38.28% |
| 2005-12-31 | $3.02 B | 61.84% |
| 2004-12-31 | $1.87 B | 86.53% |
| 2003-12-31 | $1.00 B | 75.55% |
| 2002-12-31 | $0.57 B | 26.28% |
| 2001-12-31 | $0.45 B |
Net assets for similar companies or competitors
| Company | Net assets | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $70.02 B | 301.15% | 🇺🇸 USA |
 Pfizer PFE | $92.55 B | 430.27% | 🇺🇸 USA |
 AbbVie ABBV | $8.04 B | -53.90% | 🇺🇸 USA |
 Eli Lilly LLY | $12.89 B | -26.11% | 🇺🇸 USA |
 Amgen AMGN | $5.02 B | -71.23% | 🇺🇸 USA |
 Biogen BIIB | $15.21 B | -12.84% | 🇺🇸 USA |
 Illumina ILMN | $5.73 B | -67.15% | 🇺🇸 USA |
 Vertex Pharmaceuticals VRTX | $18.54 B | 6.25% | 🇺🇸 USA |
 Merck MRK | $40.42 B | 131.59% | 🇺🇸 USA |